BTOG2: A British Thoracic Oncology Group Phase III Trial Of Gemcitabine + Cisplatin at 50mg/m2 vs Gemcitibine + Cisplatin at 80mg/m2 vs Gemcitabine + Carboplatin AUC5 In NSCLC

Project Details

Short titleBTOG2: A British Thoracic Oncology Group Phase III Trial Of Gemcitabine + Cisplatin at 50mg/m2 vs Gemcitibine + Cisplatin at 80mg/m2 vs Gemcitabine + Carboplatin AUC5 In NSCLC
StatusFinished
Effective start/end date9/09/048/09/07

Funding

  • LILLY RESEARCH CENTRE LIMITED
  • Cancer Research UK